Free HIV medicines must be given to all, not just to some

September 12, 2005

In some poor countries, free life-saving HIV medicines are being given preferentially to patients who have never taken them before (so-called 'treatment-naïve patients'), which could have disastrous consequences, says a team of researchers in Uganda.

Writing in the open access international medical journal PLoS Medicine, Robert Colebunders and colleagues from Makerere University, Kampala, give four reasons why limiting free antiretroviral medicines (ARVs) to treatment-naïve patients is problematic.

First, they say that "patients are quick to share information, and rumours spread fast regarding ways to obtain free ARVs. When patients learn that ARVs are being given at no cost only to treatment-naïve patients, they may not disclose that they have taken ARVs in the past ... Such withholding of information may result in clinicians choosing inappropriate ARVs, thereby putting patients at risk of adverse effects or of development of [drug] resistance."

Second, the authors say that forcing some patients to pay for ARVs makes it less likely that patients will obtain the drugs and take them regularly.

Third, programs that only give free ARVs to treatment-naïve patients can be slow to enrol patients into treatment. In contrast, say the authors, patients already known to be on treatment, and who are sticking to the treatment regime, can be enrolled more quickly and with less effort.

Finally, the authors believe that "selecting only ARV-naïve patients for free ARVs raises a human rights issue. Can treatment be denied to those who have somehow found money to initiate therapy--often forestalling their demise--and who are now struggling to pay for ARVs?"
-end-
Citation: Colebunders R, Kamya M, Semitala F, Castelnuovo B, Katabira E, et al. (2005) Free antiretrovirals must not be restricted only to treatment-naive patients. PLoS Med 2(10): e276.

CONTACT:
Keith McAdam
The Infectious Disease Institute
Makerere University
Kampala, Uganda
kmcadam@idi.co.ug

PLEASE MENTION PLoS MEDICINE (www.plosmedicine.org) AS THE SOURCE FOR THESE ARTICLES. THANK YOU.

All works published in PLoS Medicine are open access. Everything is immediately available without cost to anyone, anywhere--to read, download, redistribute, include in databases, and otherwise use--subject only to the condition that the original authorship is properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.

PLOS

Related Drugs Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

Wallflowers could lead to new drugs
Plant-derived chemicals called cardenolides - like digitoxin - have long been used to treat heart disease, and have shown potential as cancer therapies.

Bristol pioneers use of VR for designing new drugs
Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments.

Towards better anti-cancer drugs
The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals.

Separating drugs with MagLev
The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie.

People are more likely to try drugs for the first time during the summer
American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Drugs used to enhance sexual experiences, especially in UK
Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.

Promising new drugs for old pathogen Mtb
UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.

Can psychedelic drugs heal?
Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

New uses for existing antiviral drugs
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.

Read More: Drugs News and Drugs Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.